CABALETTA BIO, INC. Manufacturing Costs
CABALETTA BIO, INC. (CABA) reported Manufacturing Costs of $13.00 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ManufacturingCosts · last filed 2025-11-10
- CABALETTA BIO, INC. manufacturing costs for the quarter ending 2025-09-30 was $13.00M, a 168.81% increase year-over-year.
- CABALETTA BIO, INC. manufacturing costs for the quarter ending 2024-09-30 was $4.83M.
| Period end | Manufacturing Costs 3 month | Manufacturing Costs 9 month |
|---|---|---|
| 2025-09-30 | $13.00M 10-Q · filed 2025-11-10 | $29.64M 10-Q · filed 2025-11-10 |
| 2024-09-30 | $4.83M 10-Q · filed 2025-11-10 | $12.18M 10-Q · filed 2025-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |